TABLE 5.
Meta-analysis of propensity score matched analyses
95% CI
|
||||||
Assessment | N | OR/HR | lo | hi | P < | Investigators |
Any statin | 9043 | 1.27 | 1.14 | 1.41 | .001 | Lin et al68 |
Any statin | 3351 | 1.87 | 1.67 | 2.01 | .001 | Mansi et al69 |
Any statin | 6728 | 1.34 | 1.24 | 1.44 | .001 | Mansi et al51 |
Atorvastatin | 818 | 1.99 | 1.00 | 3.98 | .05 | Park et al70 |
Any statin | 1699 | 1.99 | 1.36 | 2.92 | .001 | Rha et al71 |
Any statin | 1609 | 1.66 | 1.14 | 2.42 | .001 | Vande Woestijne72 |
Any statin | 500 | 1.61 | 1.10 | 2.37 | .001 | Yamakazi73 |
Any statin | 4610 | 1.26 | 1.12 | 1.41 | .0001 | This study |
95% CI | ||||||
Meta-analysis | OR | Lo | Hi | Z-value | P-value | |
Fixed | 1.33 | 1.29 | 1.37 | 17.842 | .0001 | |
Random | 1.43 | 1.31 | 1.56 | 7.94 | .0001 | |
Heterogeneity | ||||||
Q-value | Q df | P-value | I-squared | |||
26.79 | 6 | <.0001 | 77.606 | |||
Tau squared | SE | Variance | Tau | |||
0.008 | 0.008 | 0.000 | 0.090 |